pyrroles has been researched along with Stomach Neoplasms in 79 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.27) | 18.2507 |
| 2000's | 7 (8.86) | 29.6817 |
| 2010's | 56 (70.89) | 24.3611 |
| 2020's | 15 (18.99) | 2.80 |
| Authors | Studies |
|---|---|
| Matsueda, K; Mizuno, M; Nishimura, N | 1 |
| Benhadji, KA; Casalino, S; Contarelli, S; Gaule, M; Melisi, D; Merz, V; Pesoni, C; Pietrobono, S; Quinzii, A; Zecchetto, C | 1 |
| Hotta, K; Imai, K; Ishiwatari, H; Ito, S; Kakushima, N; Kawata, N; Kishida, Y; Matsubayashi, H; Murai, K; Ono, H; Takizawa, K; Tanaka, M; Yabuuchi, Y; Yoshida, M | 1 |
| Ding, L; Huang, T; Jiang, H; Liang, Y; Liu, Y; Sattar, S; Shang, Y; Wang, M; Wei, Y; Wu, B; Yang, T; Zhang, D; Zhou, F | 1 |
| Barry, C; Betancourt, O; Blot, V; Coronella, J; D'Hooge, F; Fujita, R; Galvan, D; Gymnopoulos, M; Hartley, JA; Howard, PW; Lieuw, V; Newman, R; Nguyen, S; Pardo, R; Patel, N; Snedden, J; Stewart, C; Vijayakrishnan, B; Villicana, J; Wojciak, J; Wong, E | 1 |
| Baloyan, D; Boon, L; Chand, AL; Dwyer, AR; Eissmann, MF; Ernst, M; Lowell, CA; Murrey, MW; O'Brien, M; O'Donoghue, RJJ; Pixley, FJ; Poh, AR; Putoczki, TL; Whitehead, L | 1 |
| An, JY; Bae, JM; Cho, HJ; Choi, MG; Her, NG; Hong, JY; Kang, WK; Kim, HJ; Kim, JS; Kim, JY; Kim, KM; Kim, M; Kim, S; Kim, ST; Koo, H; Lee, IK; Lee, J; Lee, JH; Lee, Y; Lim, HY; Nam, DH; Park, JO; Park, SH; Sa, JK; Seo, YJ; Shin, YJ; Sim, MH; Sohn, TS | 1 |
| Doi, A; Matsueda, K; Mizuno, M; Mouri, H; Nishimura, N; Okada, H; Shimodate, Y; Takayama, H; Takezawa, R; Yamamoto, S | 1 |
| Dohi, O; Fukui, A; Horie, R; Horii, Y; Ishida, T; Itoh, Y; Majima, A; Naito, Y; Tomatsuri, N; Tomie, A; Tsuji, T; Yagi, N; Yamada, N; Yamada, S; Yasuda, T; Zen, K | 1 |
| Chen, Y; Feng, D; Jiang, R; Li, G; Liu, S; Peng, R; Wei, L; Zheng, S | 1 |
| Corbett, S; Hartley, JA; Howard, PW; Huang, S; van Berkel, PH; Zammarchi, F | 1 |
| Fujino, T; Hiratsuka, T; Kato, Y; Miwa, W; Sato, K | 1 |
| Bao, H; Chen, P; Li Mu Jiang, ABDRHM; Ma, X; Pang, L; Wu, J; Wu, T; Zhu, Y | 1 |
| Graham, DY; Howden, CW | 1 |
| Chen, X; Cheng, S; Dai, X; Ding, L; Guo, H; Guo, Q; Wang, J; Wang, T; Xu, X; Zhang, W | 1 |
| Fujiki, S; Gotoda, T; Ishiguro, M; Kawai, D; Kono, Y; Okanoue, S; Takemoto, K; Takenaka, R; Tsugeno, H | 1 |
| Arai, M; Fukuda, K; Hasatani, K; Honda, T; Ikeya, T; Ishii, N; Kawai, T; Kiyotoki, S; Niikura, R; Nishida, T; Shiratori, Y; Sumiyoshi, T; Yoshida, N | 1 |
| Kubo, N; Takeuchi, N | 1 |
| Avniel-Polak, S; Gross, DJ; Grozinsky-Glasberg, S; Uri, I | 1 |
| Fushimi, S; Horikawa, Y; Kato, Y; Mimori, N; Mizutamari, H; Okubo, S; Sato, S | 1 |
| Fujisaki, J; Hirasawa, T; Horiuchi, Y; Ishiyama, A; Muramatsu, Y; Sasaki, Y; Tsuchida, T; Yamasaki, A; Yoshio, T | 1 |
| Aoyama, T; Cho, H; Hayashi, T; Kano, K; Maezawa, Y; Masuda, M; Ogata, T; Oshima, T; Rino, Y; Sato, T; Yamada, T; Yoshikawa, T; Yukawa, N | 1 |
| Harada, S; Higuchi, K; Hirai, A; Kawaguchi, S; Kojima, Y; Ota, K; Takahashi, Y; Takeuchi, T; Tokioka, S; Tominaga, K | 1 |
| Al-Batran, SE; Galle, PR; Gehrke, N; Goepfert, K; Grimminger, P; Hegewisch-Becker, S; Maderer, A; Möhler, M; Nagel, M; Schattenberg, JM; Schulz, J; Thomaidis, T; Thuss-Patience, PC | 1 |
| Akasaka, T; Arao, M; Fukui, K; Hamada, K; Hanaoka, N; Higashino, K; Iishi, H; Ishihara, R; Iwatsubo, T; Kanesaka, T; Kato, M; Matsuura, N; Nakahira, H; Okada, H; Shichijo, S; Shimokawa, T; Suzuki, S; Takeuchi, Y; Tonai, Y; Uedo, N; Yamamoto, S; Yamasaki, Y | 1 |
| Jaruvongvanich, V; Poonsombudlert, K; Ungprasert, P | 1 |
| Kim, EH; Lee, JG; Nam, E; Park, CH; Park, SW | 1 |
| Eto, T; Ichida, T; Kusano, F; Sakai, Y; Ueyama, S | 1 |
| Chen, QT; He, HS; Li, BY; Shi, B; Shi, J; Song, CY | 1 |
| Meng, CX; Takagi, T; Tian, YS; Zhou, Y | 1 |
| Akazawa, Y; Asaoka, D; Hojo, M; Komori, H; Matsumoto, K; Nagahara, A; Takeda, T; Ueyama, H; Watanabe, S; Yao, T | 1 |
| Dimasi, N; Dixit, R; Fazenbaker, C; Fleming, R; Gao, C; Hinrichs, MJ; Howard, P; Masterson, L; Muniz-Medina, V; Reed, M; Rosenthal, K; Ruddle, BT; Strout, P; White, JB; Wu, H; Zhong, H | 1 |
| Choi, CW; Kang, DH; Kim, HW; Kim, SJ; Ko, J; Park, SB | 1 |
| Boussioutas, A; Brunnberg, J; Buchert, M; Dijkstra, C; Eissmann, MF; Ernst, M; Etemadi, N; Grimbaldeston, MA; Hibbs, ML; Huntington, ND; Jarnicki, A; Masson, F; O'Donoghue, RJJ; Phesse, T; Poh, AR; Thiem, S; Tsantikos, E | 1 |
| Rongrong, S; Sun, S; Xiaowu, L; Yangmei, Z; Youwei, Z; Yuan, Y | 1 |
| Wang, Q; Zhang, Y | 1 |
| Du, Z; He, J; He, X; Li, M; Li, Q; Tang, R; Wen, F; Yin, X; Zhang, P; Zhou, Y | 1 |
| Boku, N; Hashigaki, S; Kimura, N; Lechuga, M; Machida, N; Miyata, Y; Muro, K; Suzuki, M | 1 |
| Khagi, S; Saif, MW | 1 |
| Baba, H; Esaki, T; Fuse, N; Gotoh, M; Hara, T; Hosaka, H; Koizumi, W; Muro, K; Nakayama, N; Nishina, T; Sasaki, T; Sasaki, Y; Takagi, M; Takinishi, Y; Yamaguchi, K | 1 |
| Bai, Y; Davies, BR; Han, S; Ji, Q; Li, J; Liu, YJ; Tang, L; Wang, H; Xu, Y; Yin, X; Yu, DH; Zhang, J; Zhou, M | 1 |
| Bang, YJ; Khosravan, R; Lechuga, MJ; Lee, KW; Lee, SY; Lin, X; Oh, DY; Park, SR; Park, YI; Roh, EJ; Valota, O | 1 |
| Choi, MK; Hong, JY; Jung, HA; Kang, WK; Lee, J; Lim, HY; Maeng, CH; Park, JO; Park, SH; Park, YS; Yi, JH | 1 |
| Boku, N; Endo, M; Fukutomi, A; Funakoshi, T; Kenmotsu, H; Machida, N; Onozawa, Y; Todaka, A; Tsushima, T; Yamazaki, K; Yasui, H; Yokota, T | 1 |
| Aiello, E; Colarossi, C; Colarossi, L; Espina, V; Iuppa, A; Liotta, L; Memeo, L; Mueller, C | 1 |
| Beuselinck, B; Jean-Baptiste, J; Schöffski, P; Van Keerberghen, CA; Wolter, P; Zucman-Rossi, J | 1 |
| Grandhi, MS; Lafaro, KJ; Pawlik, TM | 1 |
| Kunz, PL; Phan, AT; Reidy-Lagunes, DL | 1 |
| Gardner, EE; Rudin, CM | 1 |
| Allen, E; Hanahan, D; Li, L; Miéville, P; Peng, MW; Saghafinia, S; Warren, CM | 1 |
| Hasui, T; Inaba, T; Ishida, M; Ishikawa, S; Iwamuro, M; Izumikawa, K; Kagawa, T; Kuraoka, S; Matsuura, M; Sakakihara, I; Sasaki, K; Takahashi, S; Tanaka, S; Wato, M; Yamamoto, K | 1 |
| Arai, M; Ishigami, H; Kasamatsu, S; Katsuno, T; Maruoka, D; Matsumura, T; Nakagawa, T; Okimoto, K; Saito, K; Taida, T; Yokosuka, O | 1 |
| Al-Batran, SE; Galle, PR; Gepfner-Tuma, I; Hegewisch-Becker, S; Kanzler, S; Koenig, J; Kullmann, F; Maderer, A; Moehler, M; Otte, M; Rafiyan, MR; Ruessel, J; Schimanski, CC; Schmoll, HJ; Schollenberger, L; Siveke, JT; Thuss-Patience, PC; von Weikersthal, LF; Weißinger, F; Weusmann, J; Wilke, H | 1 |
| Ding, Y; Feng, J; Fu, X; Yang, B; Yu, C; Zeng, D | 1 |
| Chae, H; Chang, HM; Cho, H; Hong, SM; Hong, YS; Kang, YK; Kim, KP; Kim, SC; Kim, TW; Ryoo, BY; Ryu, MH; Song, MJ; Yoo, C | 1 |
| Azouz, MM; Bouassida, M; Chelbi, E; El Bouchtili, S; Ezzine, H; Hamzaoui, L; Mahmoudi, M; Medhioub, M; Touinsi, H | 1 |
| Chen, J; Chen, M; Feng, ST; Huang, K; Li, ZP; Lin, Y; Luo, Y; Xu, L | 1 |
| Izumi, M; Kato, S; Kato, Y; Masui, Y; Nakajima, A; Tanida, E; Tsuchiya, I | 1 |
| Ma, HB; Ning, YL; Qi, CJ; Qian, KQ; Wang, SZ; Zhang, XG | 1 |
| Hirakawa, K; Kaizaki, R; Matsuoka, T; Matsuzaki, T; Miwa, A; Nakamura, K; Shinto, O; Tendo, M; Yashiro, M | 1 |
| Galle, PR; Gockel, I; Heidel, F; Lang, H; Lyros, O; Moehler, M; Mueller, A; Schimanski, CC | 1 |
| Bang, YJ; Boku, N; Chen, JS; Chung, HC; Doi, T; Kang, WK; Kang, YK; Lechuga, MJ; Lu, DR; Ng, WT; Qin, S; Ruiz-Garcia, A; Shen, L; Sobrero, A; Sun, Y; Tursi, JM | 1 |
| Cejka, D; Crevenna, R; Fuereder, T; Hoeflmayer, D; Jaeger-Lansky, A; Koehrer, S; Preusser, M; Strommer, S; Wacheck, V | 1 |
| Chen, P; Fink, BE; Gavai, AV; Goyal, B; Kim, SH; Lee, FY; Mastalerz, H; Norris, D; Oppenheimer, S; Tokarski, JS; Vite, GD; Wong, TW; Zhang, H; Zhao, Y | 1 |
| Al-Batran, SE; Biesterfeld, S; Ebert, MP; Galle, PR; Hartmann, JT; Kabisch, M; Lordick, F; Moehler, M; Mueller, A; Reimer, P; Trarbach, T; Wachtlin, D; Weihrauch, M | 1 |
| Danser, AH; de Krijger, RR; Eechoute, K; Kappers, MH; Leijten, F; Mathijssen, RH; Sleijfer, S; Smedts, FM; van den Meiracker, AH; van Esch, JH; Visser, TJ | 1 |
| Bennett, JJ; Rubino, MS | 1 |
| Bang, YJ; Han, SW; Hur, HS; Im, SA; Kim, HP; Kim, TY; Kim, WH; Lee, KH; Min, A; Song, SH; Yoon, YK; Youn Oh, D | 1 |
| George, S; Hornick, JL; Jagannathan, JP; Ramaiya, NH; Shinagare, AB | 1 |
| Kang, WK; Lee, J; Lim, HY; Park, JO; Park, SH; Park, YS; Yi, JH; Yim, DS | 1 |
| Bellmunt, J; Gil-Martín, M; Gómez-Martín, C; Khosravan, R; Lechuga, MJ; Lin, X; Montagut, C; Núñez, JA; Puig, M; Salazar, R; Tursi, JM | 1 |
| Banno, H; Ikeda, Y; Ishikawa, T; Kamiguchi, H; Kamiyama, K; Kawakita, Y; Miki, H; Miwa, K; Ohta, Y; Seto, M; Tamura, T; Tanaka, T; Yusa, T | 1 |
| Susman, E | 1 |
| Katoh, M | 1 |
| Jiang, XT; Tao, HQ; Zou, SC | 1 |
| An, Y; Borzilleri, RM; Cai, ZW; Chen, XT; Chen, Z; Fargnoli, J; Gullo-Brown, J; Hunt, JT; Huynh, T; Kellar, K; Lombardo, LJ; Manne, V; Nirschl, DS; Poss, M; Sack, J; Schroeder, GM; Tokarski, JS; Vaccaro, W; Wautlet, B; Wei, D; Williams, DK; Wong, TW | 1 |
| An, Y; Borzilleri, RM; Cai, ZW; Chen, XT; Cornelius, LA; Fargnoli, J; Hunt, JT; Kamath, A; Kim, K; Lombardo, LJ; Manne, V; Marathe, P; Sack, JS; Schmidt, RJ; Schroeder, GM; Tokarski, JS; Wei, D; Williams, DK; Zhang, Y | 1 |
| Amishiro, N; Gomi, K; Kobayashi, E; Nagamura, S; Saito, H | 1 |
| Hynes, NE; Lane, HA; Motoyama, AB | 1 |
7 review(s) available for pyrroles and Stomach Neoplasms
| Article | Year |
|---|---|
Development of white globe appearance lesions in the noncancerous stomach after vonoprazan administration: a report of two cases with a literature review.
Topics: Aged; Female; Humans; Male; Proton Pump Inhibitors; Pyrroles; Stomach; Stomach Neoplasms; Sulfonamides | 2021 |
Update in the Therapy of Advanced Neuroendocrine Tumors.
Topics: Combined Modality Therapy; Cytoreduction Surgical Procedures; Everolimus; Humans; Indoles; Intestinal Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Somatostatin; Stomach Neoplasms; Sunitinib | 2017 |
Vonoprazan versus proton-pump inhibitors for gastric endoscopic submucosal dissection-induced ulcers: a systematic review and meta-analysis.
Topics: Endoscopic Mucosal Resection; Humans; Proton Pump Inhibitors; Pyrroles; Stomach Neoplasms; Stomach Ulcer; Sulfonamides; Wound Healing | 2018 |
Comparative efficacy of various anti-ulcer medications after gastric endoscopic submucosal dissection: a systematic review and network meta-analysis.
Topics: Anti-Ulcer Agents; Endoscopic Mucosal Resection; Humans; Network Meta-Analysis; Odds Ratio; Proton Pump Inhibitors; Pyrroles; Stomach Neoplasms; Stomach Ulcer; Sulfonamides; Wound Healing | 2019 |
Comparison of the Use of Vonoprazan and Proton Pump Inhibitors for the Treatment of Peptic Ulcers Resulting from Endoscopic Submucosal Dissection: A Systematic Review and Meta-Analysis.
Topics: Endoscopic Mucosal Resection; Humans; Peptic Ulcer; Postoperative Complications; Proton Pump Inhibitors; Pyrroles; Stomach Neoplasms; Sulfonamides; Treatment Outcome; Wound Healing | 2019 |
Role of Locoregional and Systemic Approaches for the Treatment of Patients with Metastatic Neuroendocrine Tumors.
Topics: Antineoplastic Agents; Humans; Indoles; Intestinal Neoplasms; Liver Neoplasms; Liver Transplantation; Neuroendocrine Tumors; Pancreatic Neoplasms; Prognosis; Pyrroles; Stomach Neoplasms; Sunitinib | 2015 |
FGF signaling network in the gastrointestinal tract (review).
Topics: Amino Acid Sequence; Animals; Base Sequence; Colon; Fibroblast Growth Factors; Gastric Mucosa; Gene Expression Regulation, Neoplastic; Humans; Indoles; Molecular Sequence Data; Oxindoles; Propionates; Protein Kinase Inhibitors; Pyrroles; Receptors, Fibroblast Growth Factor; Recombinant Proteins; Signal Transduction; Stomach Neoplasms; Stomatitis; Wnt Proteins | 2006 |
17 trial(s) available for pyrroles and Stomach Neoplasms
| Article | Year |
|---|---|
Vonoprazan versus lansoprazole in the treatment of artificial gastric ulcers after endoscopic submucossal dissection: a randomized, open-label trial.
Topics: Dissection; Endoscopic Mucosal Resection; Humans; Lansoprazole; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Stomach Neoplasms; Stomach Ulcer; Sulfonamides | 2021 |
Comparison of the Effects of Vonoprazan and Lansoprazole for Treating Endoscopic Submucosal Dissection-Induced Artificial Ulcers.
Topics: Adenoma; Aged; Aged, 80 and over; Endoscopic Mucosal Resection; Female; Humans; Lansoprazole; Male; Middle Aged; Postoperative Complications; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Stomach Neoplasms; Stomach Ulcer; Sulfonamides | 2018 |
Cytokeratin-18 fragments predict treatment response and overall survival in gastric cancer in a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Disease-Free Survival; Female; Fluorouracil; Humans; Indoles; Keratin-18; Leucovorin; Male; Middle Aged; Peptide Fragments; Placebos; Pyrroles; Stomach Neoplasms; Sunitinib | 2018 |
Efficacy of vonoprazan in prevention of bleeding from endoscopic submucosal dissection-induced gastric ulcers: a prospective randomized phase II study.
Topics: Aged; Endoscopic Mucosal Resection; Female; Hematemesis; Hemoglobins; Humans; Lansoprazole; Male; Melena; Middle Aged; Postoperative Hemorrhage; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Stomach Neoplasms; Stomach Ulcer; Sulfonamides | 2019 |
Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection.
Topics: Aged; Aged, 80 and over; Alanine; Anti-Ulcer Agents; Drug Therapy, Combination; Endoscopic Mucosal Resection; Esomeprazole; Female; Humans; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Quinolones; Severity of Illness Index; Stomach Neoplasms; Stomach Ulcer; Sulfonamides; Wound Healing | 2019 |
A prospective randomized trial of a potassium competitive acid blocker vs proton pump inhibitors on the effect of ulcer healing after endoscopic submucosal dissection of gastric neoplasia.
Topics: Aged; Endoscopic Mucosal Resection; Female; Follow-Up Studies; Humans; Male; Postoperative Complications; Prognosis; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Stomach Neoplasms; Stomach Ulcer; Sulfonamides; Wound Healing | 2019 |
Dose-related healing of artificial ulcers after endoscopic submucosal dissection using esomeprazole: A randomized controlled study.
Topics: Endoscopic Mucosal Resection; Esomeprazole; Female; Humans; Male; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Republic of Korea; Stomach Neoplasms; Stomach Ulcer; Sulfonamides; Ulcer; Wound Healing | 2019 |
Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Asian People; Cisplatin; Drug Combinations; Female; Humans; Indoles; Male; Maximum Tolerated Dose; Middle Aged; Oxonic Acid; Pyrroles; Stomach Neoplasms; Sunitinib; Tegafur; Treatment Outcome | 2014 |
Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer.
Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Combinations; Female; Humans; Indoles; Male; Middle Aged; Oxindoles; Oxonic Acid; Propionates; Pyrroles; Stomach Neoplasms; Survival Rate; Tegafur | 2013 |
Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Drug Administration Schedule; Female; Fluorouracil; Humans; Indoles; Male; Maximum Tolerated Dose; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Pyrroles; Stomach Neoplasms; Sunitinib | 2013 |
Vonoprazan prevents bleeding from endoscopic submucosal dissection-induced gastric ulcers.
Topics: Adenoma; Aged; Aged, 80 and over; Endoscopic Mucosal Resection; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Postoperative Complications; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Stomach Neoplasms; Stomach Ulcer; Sulfonamides; Wound Healing | 2016 |
Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Disease-Free Survival; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Esophageal Neoplasms; Female; Fluorouracil; Humans; Indoles; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Pyrroles; Stomach Neoplasms; Sunitinib | 2016 |
Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: Prospective randomized controlled trial.
Topics: Aged; Aged, 80 and over; Endoscopic Mucosal Resection; Esomeprazole; Female; Humans; Male; Postoperative Complications; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Stomach Neoplasms; Stomach Ulcer; Sulfonamides | 2017 |
Phase II study of sunitinib as second-line treatment for advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Esophagogastric Junction; Female; Humans; Indoles; Male; Middle Aged; Protein Kinase Inhibitors; Pyrroles; Quality of Life; Stomach Neoplasms; Sunitinib; Treatment Outcome | 2011 |
An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Indoles; Male; Middle Aged; Mutation; Prospective Studies; Protein-Tyrosine Kinases; Pyrroles; Stomach Neoplasms; Sunitinib; Treatment Outcome | 2011 |
Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Female; Fluorouracil; Humans; Indoles; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Platinum; Pyrroles; Salvage Therapy; Stomach Neoplasms; Sunitinib; Survival Rate; Taxoids; Tissue Distribution; Treatment Outcome; Young Adult | 2012 |
A phase I, dose-finding study of sunitinib combined with cisplatin and 5-fluorouracil in patients with advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Dose-Response Relationship, Drug; Female; Fluorouracil; Follow-Up Studies; Humans; Indoles; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Prognosis; Pyrroles; Stomach Neoplasms; Sunitinib; Survival Rate; Tissue Distribution | 2013 |
55 other study(ies) available for pyrroles and Stomach Neoplasms
| Article | Year |
|---|---|
Gastroduodenal Intussusception Due to Vonoprazan-induced Gastric Polyps.
Topics: Adenomatous Polyps; Gastric Fundus; Humans; Intussusception; Polyps; Pyrroles; Stomach Neoplasms; Sulfonamides | 2022 |
Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports.
Topics: Humans; Pyrazoles; Pyrimidines; Pyrroles; Receptor, Fibroblast Growth Factor, Type 2; Stomach Neoplasms | 2022 |
Incidence of Delayed Bleeding among Patients Continuing Antithrombotics during Gastric Endoscopic Submucosal Dissection.
Topics: Aged; Aged, 80 and over; Anti-Ulcer Agents; Endoscopic Mucosal Resection; Female; Fibrinolytic Agents; Humans; Male; Postoperative Hemorrhage; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Stomach Neoplasms; Stomach Ulcer; Sulfonamides; Time Factors | 2019 |
TGF-β receptor inhibitor LY2109761 enhances the radiosensitivity of gastric cancer by inactivating the TGF-β/SMAD4 signaling pathway.
Topics: Animals; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Nude; Neoplasms, Experimental; Pyrazoles; Pyrroles; Radiation Tolerance; Signal Transduction; Smad4 Protein; Stomach Neoplasms; Transforming Growth Factor beta | 2019 |
TR1801-ADC: a highly potent cMet antibody-drug conjugate with high activity in patient-derived xenograft models of solid tumors.
Topics: Animals; Antineoplastic Agents; Benzodiazepines; Biliary Tract Neoplasms; Cell Line, Tumor; Colonic Neoplasms; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Immunoconjugates; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Oncogenes; Proto-Oncogene Proteins c-met; Pyrroles; Rats; Rats, Sprague-Dawley; Stomach Neoplasms; Tissue Array Analysis; Xenograft Model Antitumor Assays | 2020 |
Inhibition of the SRC Kinase HCK Impairs STAT3-Dependent Gastric Tumor Growth in Mice.
Topics: Animals; Female; Humans; Macrophage Activation; Male; Mice; Mice, Transgenic; Phosphorylation; Proto-Oncogene Proteins c-hck; Pyrimidines; Pyrroles; STAT3 Transcription Factor; Stomach Neoplasms; Survival Rate | 2020 |
Comprehensive pharmacogenomic characterization of gastric cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; DNA-Binding Proteins; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Mutation; Pharmacogenomic Variants; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Stomach Neoplasms; Transcriptome; Tumor Cells, Cultured; Wnt Signaling Pathway | 2020 |
Effect of Vonoprazan on Delayed Bleeding after Endoscopic Submucosal Dissection for Gastric Neoplasia among Antithrombotic Drug Users: A Single-Center, Single-Arm Prospective Observational Case Control Study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Case-Control Studies; Endoscopy, Gastrointestinal; Female; Humans; Male; Middle Aged; Postoperative Hemorrhage; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Risk Factors; Stomach Neoplasms; Sulfonamides | 2020 |
Clinical Outcomes of Vonoprazan-Treated Patients after Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Multicenter Observation Study.
Topics: Aged; Endoscopic Mucosal Resection; Female; Humans; Male; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Stomach Neoplasms; Stomach Ulcer; Sulfonamides | 2021 |
Resistance to FGFR1-targeted therapy leads to autophagy via TAK1/AMPK activation in gastric cancer.
Topics: Adenocarcinoma; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Autophagy; Benzamides; Cell Culture Techniques; Cell Line, Tumor; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Humans; MAP Kinase Kinase Kinases; Mice; Mice, Inbred BALB C; Piperazines; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Pyrroles; Receptor, Fibroblast Growth Factor, Type 1; Signal Transduction; Stomach Neoplasms | 2020 |
The Role of Specific ATP-Binding Cassette Transporters in the Acquired Resistance to Pyrrolobenzodiazepine Dimer-Containing Antibody-Drug Conjugates.
Topics: Antibodies, Monoclonal, Humanized; ATP Binding Cassette Transporter, Subfamily G, Member 2; Benzodiazepines; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunoconjugates; Lymphoma, Large-Cell, Anaplastic; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pyrroles; Stomach Neoplasms | 2020 |
Study of Fe₃O₄-PPy Core-Shell Nanocomposite in the Diagnosis of Tumor Markers in the Tissues of Early Gastric Cancer Patients.
Topics: Biomarkers, Tumor; Humans; Nanocomposites; Polymers; Prognosis; Pyrroles; Stomach Neoplasms | 2021 |
Recent Developments Pertaining to H. pylori Infection.
Topics: Adenocarcinoma; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Pyrroles; Rifabutin; Stomach Neoplasms; Sulfonamides; Tetracycline; Treatment Outcome | 2021 |
Ceritinib increases sensitivity of AKT inhibitors to gastric cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Female; Glycogen Synthase Kinase 3 beta; Humans; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrazoles; Pyrimidines; Pyrroles; Signal Transduction; Stomach Neoplasms; Sulfones; Thiophenes; Tumor Burden; Xenograft Model Antitumor Assays | 2021 |
Vonoprazan versus proton pump inhibitors for postendoscopic submucosal dissection bleeding in the stomach: a multicenter population-based comparative study.
Topics: Dissection; Endoscopic Mucosal Resection; Humans; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Stomach Neoplasms; Stomach Ulcer; Sulfonamides | 2022 |
Gastrointestinal stromal tumor of the stomach with axillary lymph node metastasis: A case report.
Topics: Aged; Axilla; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Metastasis; Phenylurea Compounds; Positron-Emission Tomography; Pyridines; Pyrroles; Stomach Neoplasms; Sunitinib; Tomography, X-Ray Computed | 2017 |
Short-term efficacy of potassium-competitive acid blocker following gastric endoscopic submucosal dissection: a propensity score analysis.
Topics: Aged; Aged, 80 and over; Endoscopic Mucosal Resection; Female; Humans; Japan; Lansoprazole; Logistic Models; Middle Aged; Multivariate Analysis; Postoperative Complications; Potassium; Propensity Score; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Stomach; Stomach Neoplasms; Stomach Ulcer; Sulfonamides; Treatment Outcome | 2018 |
Vonoprazan is Superior to Rabeprazole for Healing Endoscopic Submucosal Dissection: Induced Ulcers.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Drug Substitution; Endoscopic Mucosal Resection; Female; Gastroscopy; Humans; Male; Middle Aged; Postoperative Complications; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Retrospective Studies; Stomach; Stomach Neoplasms; Stomach Ulcer; Sulfonamides | 2018 |
[A Long-Term Survivor Who Are Responding to Sunitinib Treatment for Recurrent Imatinib-Resistant Gastrointestinal Stromal Tumor(GIST)of the Stomach].
Topics: Antineoplastic Agents; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Male; Middle Aged; Pyrroles; Recurrence; Stomach Neoplasms; Sunitinib; Time Factors | 2017 |
Vonoprazan versus proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: Protocol for meta-analysis of randomized controlled trials and observational studies.
Topics: Endoscopic Mucosal Resection; Epidemiologic Studies; Gastrointestinal Hemorrhage; Humans; Meta-Analysis as Topic; Postoperative Complications; Proton Pump Inhibitors; Pyrroles; Randomized Controlled Trials as Topic; Research Design; Stomach Neoplasms; Stomach Ulcer; Sulfonamides; Systematic Review as Topic; Time Factors | 2019 |
Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimer.
Topics: Animals; Antineoplastic Agents; Benzodiazepines; Female; Humans; Immunoconjugates; MCF-7 Cells; Mice, Nude; Pyrroles; Rats; Receptor, ErbB-2; Stomach Neoplasms; Trastuzumab; Xenograft Model Antitumor Assays | 2019 |
IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization.
Topics: Aminopyridines; Animals; Cell Degranulation; Cromolyn Sodium; Disease Models, Animal; Epithelium; Female; Gastric Mucosa; Humans; Interleukin-1 Receptor-Like 1 Protein; Interleukin-33; Macrophages; Male; Mast Cells; Mice; Mice, Transgenic; Pyrroles; Signal Transduction; Stomach Neoplasms; Tissue Array Analysis; Tumor Microenvironment | 2019 |
Sotrastaurin attenuates the stemness of gastric cancer cells by targeting PKCδ.
Topics: Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Humans; Neoplasm Metastasis; Neoplastic Stem Cells; Protein Kinase C-delta; Pyrroles; Quinazolines; Stomach Neoplasms | 2019 |
Sunitinib reverse multidrug resistance in gastric cancer cells by modulating Stat3 and inhibiting P-gp function.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Resistance, Multiple; Humans; Indoles; Pyrroles; Rhodamine 123; RNA, Messenger; STAT3 Transcription Factor; Stomach Neoplasms; Sunitinib; Vincristine | 2013 |
Cost analysis of S1 and XELOX as adjuvant therapy for gastric cancer.
Topics: Acenaphthenes; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged; Oxaloacetates; Pyrroles; Retrospective Studies; Stomach Neoplasms; Treatment Outcome; Young Adult | 2013 |
Neuroendocrine tumors: treatment updates.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Everolimus; Humans; Indoles; Intestinal Neoplasms; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Pyrroles; Sirolimus; Stomach Neoplasms; Sunitinib; Treatment Outcome | 2013 |
The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asian People; Cell Line, Tumor; Cell Proliferation; China; Disease Models, Animal; Docetaxel; Female; Humans; Immunohistochemistry; Mice; Mice, Nude; Mutation; Nuclear Proteins; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyrimidines; Pyrroles; Stomach Neoplasms; Taxoids; Transcription Factors; Treatment Outcome; Xenograft Model Antitumor Assays | 2013 |
Effects of single nucleotide polymorphisms on treatment outcomes and toxicity in patients treated with sunitinib.
Topics: Adult; Aged; Antineoplastic Agents; Biliary Tract Neoplasms; Disease-Free Survival; Female; Genetic Association Studies; Homozygote; Humans; Indoles; Kaplan-Meier Estimate; Male; Middle Aged; Polymorphism, Single Nucleotide; Proportional Hazards Models; Pyrroles; Stomach Neoplasms; Sunitinib; Treatment Failure; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2013 |
Clinicopathological features and outcomes of gastric cancer patients with pulmonary lymphangitis carcinomatosa.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Humans; Indoles; Kaplan-Meier Estimate; Lung Diseases; Lymphangitis; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Pyrroles; Retrospective Studies; Stomach Neoplasms; Sunitinib; Tegafur; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Inhibition of histone deacetylase 4 increases cytotoxicity of docetaxel in gastric cancer cells.
Topics: Acetylation; Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; Biomarkers; Cell Line, Tumor; Cell Survival; Cisplatin; Docetaxel; Drug Synergism; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Immunohistochemistry; Male; Middle Aged; Pyrroles; Repressor Proteins; Stomach Neoplasms; Taxoids | 2014 |
Direct Visualization of the Antiangiogenic Effects of Sunitinib During the Treatment of Metastatic Clear Cell Renal Cell Carcinoma.
Topics: Aged; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Endoscopy, Gastrointestinal; Humans; Indoles; Kidney Neoplasms; Male; Pyrroles; Stomach Neoplasms; Sunitinib; Treatment Outcome | 2015 |
New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.
Topics: Antineoplastic Agents; Everolimus; Hormones; Humans; Indoles; Intestinal Neoplasms; Intestines; Molecular Targeted Therapy; Neuroendocrine Tumors; Octreotide; Pancreas; Pancreatic Neoplasms; Pyrroles; Somatostatin; Stomach; Stomach Neoplasms; Sunitinib | 2015 |
Drug therapy: Preclinical oncology - reporting transparency needed.
Topics: Animals; Antineoplastic Agents; Carcinoma, Neuroendocrine; Carcinoma, Renal Cell; Clinical Trials as Topic; Evidence-Based Medicine; Gastrointestinal Stromal Tumors; Humans; Indoles; Kidney Neoplasms; Medical Oncology; Meta-Analysis as Topic; Neoplasms; Pancreatic Neoplasms; Practice Guidelines as Topic; Pyrroles; Research Design; Research Report; Stomach Neoplasms; Sunitinib; Treatment Outcome | 2016 |
Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling.
Topics: Angiogenesis Inhibitors; Animals; Axitinib; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glucose; Glutamine; Glycolysis; Humans; Imidazoles; Indazoles; Indoles; Intestinal Neoplasms; Lactic Acid; Membrane Transport Proteins; Mice; Models, Biological; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Signal Transduction; Sirolimus; Stomach Neoplasms; Sunitinib; TOR Serine-Threonine Kinases; Up-Regulation | 2016 |
Vonoprazan is superior to proton pump inhibitors in healing artificial ulcers of the stomach post-endoscopic submucosal dissection: A propensity score-matching analysis.
Topics: Aged; Endoscopic Mucosal Resection; Esomeprazole; Female; Follow-Up Studies; Gastroscopy; Humans; Male; Postoperative Complications; Propensity Score; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Stomach Neoplasms; Stomach Ulcer; Sulfonamides; Treatment Outcome | 2017 |
PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
Topics: Animals; Cell Line, Tumor; Chromones; Cisplatin; Drug Resistance, Neoplasm; Humans; MAP Kinase Signaling System; Mice; Mice, Nude; Morpholines; p21-Activated Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrazoles; Pyrroles; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2014 |
Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumor.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Everolimus; Female; Humans; Indoles; Intestinal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Retrospective Studies; Stomach Neoplasms; Sunitinib | 2017 |
Gastrointestinal stromal tumours (GISTs): A descriptive study on 29 cases.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Intestine, Small; Male; Middle Aged; Proto-Oncogene Proteins c-kit; Pyrroles; Retrospective Studies; Stomach Neoplasms; Sunitinib; Survival Rate; Tumor Burden; Weight Loss | 2016 |
Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?
Topics: Adult; Antineoplastic Agents; Female; Humans; Indoles; Intestinal Neoplasms; Kaplan-Meier Estimate; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Retrospective Studies; Stomach Neoplasms; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Ligation or cross-linking of CD40 has different effects on AGS gastric cancer cells.
Topics: Apoptosis; CD40 Antigens; CD40 Ligand; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Chromones; Flow Cytometry; Humans; Indoles; Morpholines; Nuclear Proteins; Protein Kinase Inhibitors; Pyrroles; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Small Interfering; Stomach Neoplasms; Vascular Endothelial Growth Factor A | 2009 |
Synergistic antitumor effects of FGFR2 inhibitor with 5-fluorouracil on scirrhous gastric carcinoma.
Topics: Adenocarcinoma, Scirrhous; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Division; Flow Cytometry; Fluorouracil; Indoles; Mice; Pyridines; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach Neoplasms; Sunitinib | 2010 |
Analysis of anti-proliferative and chemosensitizing effects of sunitinib on human esophagogastric cancer cells: Synergistic interaction with vandetanib via inhibition of multi-receptor tyrosine kinase pathways.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Proliferation; Cells, Cultured; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Endothelium, Vascular; ErbB Receptors; Esophageal Neoplasms; Flow Cytometry; Humans; Indoles; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrroles; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Stomach Neoplasms; Sunitinib; Umbilical Veins; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factor Receptor-3 | 2010 |
mTOR inhibition by everolimus counteracts VEGF induction by sunitinib and improves anti-tumor activity against gastric cancer in vivo.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Everolimus; Female; Humans; Immunohistochemistry; Immunosuppressive Agents; Indoles; Intracellular Signaling Peptides and Proteins; Mice; Mice, Nude; Protein Serine-Threonine Kinases; Pyrroles; Sirolimus; Stomach Neoplasms; Sunitinib; TOR Serine-Threonine Kinases; Transplantation, Heterologous; Vascular Endothelial Growth Factor A | 2010 |
Novel pyrrolo[2,1-f][1,2,4]triazin-4-amines: Dual inhibitors of EGFR and HER2 protein tyrosine kinases.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; ErbB Receptors; Humans; Male; Mice; Mice, Inbred BALB C; Models, Molecular; Neoplasms; Protein-Tyrosine Kinases; Pyrroles; Receptor, ErbB-2; Stomach Neoplasms; Triazines; Xenograft Model Antitumor Assays | 2011 |
Sunitinib-induced hypothyroidism is due to induction of type 3 deiodinase activity and thyroidal capillary regression.
Topics: Aged; Animals; Antineoplastic Agents; Body Weight; Capillaries; Carcinoma, Renal Cell; Female; Gastrointestinal Stromal Tumors; Humans; Hypothyroidism; Indoles; Iodide Peroxidase; Kidney Neoplasms; Male; Middle Aged; Prospective Studies; Protein-Tyrosine Kinases; Pyrroles; Rats; Rats, Inbred WKY; Regional Blood Flow; Regression Analysis; Retrospective Studies; Stomach Neoplasms; Sunitinib; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 2011 |
Gastrointestinal stromal tumors of the stomach.
Topics: Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Gastroscopy; Humans; Imatinib Mesylate; Indoles; Laparoscopy; Mutation; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Radiotherapy, Adjuvant; Stomach Neoplasms; Sunitinib | 2012 |
Sunitinib synergizes the antitumor effect of cisplatin via modulation of ERCC1 expression in models of gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA Mutational Analysis; DNA-Binding Proteins; Down-Regulation; Drug Synergism; Endonucleases; Enzyme-Linked Immunosorbent Assay; Gene Expression; Humans; Immunohistochemistry; Indoles; Pyrroles; Receptor, Platelet-Derived Growth Factor alpha; Stomach Neoplasms; Sunitinib | 2012 |
Intracranial metastasis from pediatric GI stromal tumor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzenesulfonates; Brain Neoplasms; Drug Administration Schedule; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Piperazines; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Sorafenib; Stomach Neoplasms; Sunitinib; Treatment Outcome | 2012 |
Design and synthesis of pyrrolo[3,2-d]pyrimidine HER2/EGFR dual inhibitors: improvement of the physicochemical and pharmacokinetic profiles for potent in vivo anti-tumor efficacy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Design; ErbB Receptors; Half-Life; Humans; Mice; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Rats; Receptor, ErbB-2; Stomach Neoplasms; Sulfones; Transplantation, Heterologous | 2012 |
New drug increases survival in stomach cancer.
Topics: Gastrointestinal Stromal Tumors; Humans; Indoles; Prognosis; Pyrroles; Stomach Neoplasms; Sunitinib; Survival Analysis; Treatment Outcome | 2006 |
[Effect of angiogenesis inhibitor SU6668 on the growth and metastasis of gastric cancer in SCID mice].
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Line, Tumor; Drug Synergism; Fluorouracil; Humans; Indoles; Liver Neoplasms; Male; Mice; Mice, SCID; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Oxindoles; Propionates; Pyrroles; Stomach Neoplasms | 2006 |
Identification of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Met kinase.
Topics: Animals; Caco-2 Cells; Cell Proliferation; Cells, Cultured; Crystallography, X-Ray; Enzyme Inhibitors; Ether-A-Go-Go Potassium Channels; Glutathione Transferase; Hepatocytes; Humans; Mice; Microsomes, Liver; Molecular Structure; Protein Conformation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-met; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Stomach Neoplasms; Structure-Activity Relationship; Triazines | 2008 |
Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitors.
Topics: Aminopyridines; Animals; Humans; Mice; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyrroles; Stomach Neoplasms; Structure-Activity Relationship; Urea; Xenograft Model Antitumor Assays | 2008 |
New water-soluble duocarmycin derivatives: synthesis and antitumor activity of A-ring pyrrole compounds bearing beta-heteroarylacryloyl groups.
Topics: Adenocarcinoma; Animals; Blood Platelets; Drug Screening Assays, Antitumor; HeLa Cells; Humans; In Vitro Techniques; Indoles; Inhibitory Concentration 50; Male; Mice; Mice, Nude; Neoplasm Transplantation; Pyrroles; Sarcoma 180; Stomach Neoplasms; Structure-Activity Relationship; Transplantation, Heterologous | 1999 |
The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Betacellulin; Breast Neoplasms; Cell Division; Drug Interactions; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; G1 Phase; Growth Substances; Humans; Intercellular Signaling Peptides and Proteins; Ligands; Neuregulin-1; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; Receptor, ErbB-2; Signal Transduction; Stomach Neoplasms; Substrate Specificity; Tumor Cells, Cultured | 2002 |